Amedisys Inc. (AMED)

NASDAQ: AMED · IEX Real-Time Price · USD
133.49
-6.52 (-4.66%)
At close: Jan 25, 2022 4:00 PM
134.17
0.68 (0.51%)
After-hours:Jan 25, 2022 7:56 PM EST
Market Cap4.35B
Revenue (ttm)2.21B
Net Income (ttm)220.18M
Shares Out32.60M
EPS (ttm)6.66
PE Ratio20.05
Forward PE27.10
Dividendn/a
Ex-Dividend Daten/a
Volume286,393
Open137.01
Previous Close140.01
Day's Range130.80 - 138.05
52-Week Range127.18 - 314.84
Beta0.69
AnalystsBuy
Price Target202.93 (+52.0%)
Earnings DateFeb 22, 2022

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its...

IndustryHealth Care Providers & Services
Founded1982
CEOPaul Kusserow
Employees21,000
Stock ExchangeNASDAQ
Ticker SymbolAMED
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for Amedisys stock is "Buy." The 12-month stock price forecast is 202.93, which is an increase of 52.02% from the latest price.

Price Target
$202.93
(52.02% upside)
Analyst Consensus: Buy

News

Amedisys to Present at the 40th Annual J.P. Morgan Healthcare Conference

BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul B. K...

3 weeks ago - GlobeNewsWire

New Strong Sell Stocks for December 29th

B, FPI, CGNX, AMED, and FSUGY have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2021.

Other symbols:BCGNXFPI
3 weeks ago - Zacks Investment Research

New Strong Sell Stocks for December 27th

TXRH, VIOT, WBK, AMED and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 27, 2021

Other symbols:CGNXTXRHVIOTWBK
4 weeks ago - Zacks Investment Research

10 Bargain Stocks to Buy After Falling 30% in 2021

If you're looking for bargain stocks to buy that are down 30% or more in 2021, that's not an easy task. Here are 10 that fit the bill.

1 month ago - InvestorPlace

Why Is Amedisys (AMED) Down 22.9% Since Last Earnings Report?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

New Strong Sell Stocks for December 2nd

AMED, LGIH, SWK, TCMD, and HEINY have been added to the Zacks Rank #5 (Strong Sell) List on December 2, 2021.

Other symbols:LGIHSWKTCMD
1 month ago - Zacks Investment Research

Amedisys to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

BATON ROUGE, La., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. K...

1 month ago - GlobeNewsWire

New Strong Sell Stocks for November 26th

COLD, ENR, KSU, FSTR, and AMED have been added to the Zacks Rank #5 (Strong Sell) List on November 26, 2021.

Other symbols:COLDENRFSTR
1 month ago - Zacks Investment Research

New Strong Sell Stocks for November 19th

AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.

Other symbols:CSIIDVAGFFLTRX
2 months ago - Zacks Investment Research

Amedisys to Present at the Stephens Annual Investment Conference

BATON ROUGE, La., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. K...

2 months ago - GlobeNewsWire

New Strong Sell Stocks for November 5th

BLMN, AMED, HL, LGIH, and PLMR have been added to the Zacks Rank #5 (Strong Sell) List on November 5, 2021.

Other symbols:BLMNHLLGIHPLMR
2 months ago - Zacks Investment Research

Amedisys to Present at the Jefferies London Healthcare Conference

BATON ROUGE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul B....

2 months ago - GlobeNewsWire

Amedisys (AMED) Tops Q3 Earnings Estimates, Slashes '21 View

Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment.

2 months ago - Zacks Investment Research

Amedisys (AMED) Beats Q3 Earnings Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 12.50% and -2.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Amedisys Reports Third Quarter 2021 Financial Results Updates 2021 Guidance

BATON ROUGE, La., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2021.

2 months ago - GlobeNewsWire

Analysts Estimate Amedisys (AMED) to Report a Decline in Earnings: What to Look Out for

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Amedisys to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference

BATON ROUGE, La., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul B....

3 months ago - GlobeNewsWire

Amedisys to Open Home Health Care Centers in Charlotte and Raleigh, N.C.

BATON ROUGE, La., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory asset...

3 months ago - GlobeNewsWire

EHC or AMED: Which Is the Better Value Stock Right Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Other symbols:EHC
3 months ago - Zacks Investment Research

Can Amedisys Stock Rebound After A 5% Fall In A Week?

Last month, we discussed that Amedisys stock price could rebound over a one-month period after falling 3% in a week, based on its historical performance. However, AMED stock has seen a further decline o...

3 months ago - Forbes

Amedisys to Acquire Home Health Regulatory Assets in Charlotte and Raleigh, N.C.

BATON ROUGE, La., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire reg...

4 months ago - GlobeNewsWire

Amedisys (AMED) Down 6.5% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

7 Stocks to Buy That Could Benefit From Democrats Spending Big

Investors can capitalize on Democratic spending no matter their affiliation. Here are the stocks to buy based on boosts in renewables, health care and infrastructure.

Other symbols:CATFSLRHASIMTOSCRSEDG
4 months ago - InvestorPlace

EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Other symbols:EHC
4 months ago - Zacks Investment Research